Amphiphysin I and II are nerve terminal-enriched proteins containing SH3 domains that interact with dynamin and synaptojanin. The amphiphysins may function in synaptic vesicle endocytosis by targeting synaptojanin and dynamin to emerging endocytic buds through SH3 domain-independent interactions with clathrin and AP2. We have recently identified and cloned several amphiphysin II splice variants that differentially incorporate clathrin-binding domains. To determine whether these domains function in membrane targeting, we used immunofluorescence to examine the potential localization of amphiphysin II variants to clathrin-coated pits on plasma membranes purified from transfected COS-7 cells. Full-length amphiphysin II targets to the plasma membrane where it partially co-localizes with clathrin. However, splice variants and deletion constructs lacking clathrin-binding domains still target to the plasma membrane, and removal of clathrin from the membrane does not affect amphiphysin II distribution. Surprisingly, plasma membrane targeting was dependent on the presence of a 31-amino acid alternatively spliced sequence at the N terminus of amphiphysin II, a result confirmed using subcellular fractionation. In binding assays, the 31-amino acid sequence was also found to facilitate amphiphysin dimerization mediated through the N terminus. Taken together, these data support a role for the N terminus of amphiphysin II in membrane targeting during endocytosis.
Amphiphysin I and II are nerve terminal-enriched proteins containing SH3 domains that interact with dynamin and synaptojanin. The amphiphysins may function in synaptic vesicle endocytosis by targeting synaptojanin and dynamin to emerging endocytic buds through SH3 domain-independent interactions with clathrin and AP2. We have recently identified and cloned several amphiphysin II splice variants that differentially incorporate clathrin-binding domains. To determine whether these domains function in membrane targeting, we used immunofluorescence to examine the potential localization of amphiphysin II variants to clathrin-coated pits on plasma membranes purified from transfected COS-7 cells. Full-length amphiphysin II targets to the plasma membrane where it partially co-localizes with clathrin. However, splice variants and deletion constructs lacking clathrin-binding domains still target to the plasma membrane, and removal of clathrin from the membrane does not affect amphiphysin II distribution. Surprisingly, plasma membrane targeting was dependent on the presence of a 31-amino acid alternatively spliced sequence at the N terminus of amphiphysin II, a result confirmed using subcellular fractionation. In binding assays, the 31-amino acid sequence was also found to facilitate amphiphysin dimerization mediated through the N terminus. Taken together, these data support a role for the N terminus of amphiphysin II in membrane targeting during endocytosis.
Clathrin-dependent endocytosis plays an important role in the recycling of synaptic vesicles in the presynaptic nerve terminal (1) . A number of the components of the molecular machinery that function in this process have been identified including clathrin, the clathrin adaptor AP2, dynamin, synaptojanin, and the amphiphysins. Dynamin is a GTPase that forms collared rings around deeply invaginated pits and is involved in the formation of clathrin-coated vesicles from the plasma membrane (2) (3) (4) . Synaptojanin is an inositol 5-phosphatase (5-7) that is enriched in nerve terminals where it is present on endocytic intermediates (8, 9) . The roles of the amphiphysins (which consist of two major gene products, amphiphysin I and II) in endocytosis remain poorly defined.
One possible function for the amphiphysins is to target synaptojanin and dynamin to emerging clathrin-coated buds at the plasma membrane during synaptic vesicle endocytosis. Indeed, both amphiphysin I and II, which form heterodimers (10) , are enriched in nerve terminals where they demonstrate SH3 domain-dependent interactions with synaptojanin and dynamin (5, 10 -15) . Interestingly, the association of synaptojanin and dynamin with the amphiphysin dimer is regulated by the state of amphiphysin phosphorylation (16) , and overexpression of amphiphysin SH3 domains blocks transferrin receptor endocytosis (17, 18) , suggesting that this interaction is critical for normal endocytic function. Further, overexpression of the amphiphysin I SH3 domain in the lamprey giant reticulospinal synapse blocks synaptic vesicle endocytosis, likely by preventing dynamin targeting to clathrin-coated pits (CCPs) (19) . 1 For the amphiphysins to have an adaptor function in endocytosis, they need a mechanism for targeting to the plasma membrane at or near the endocytic site. Such a role may be played by AP2, a component of CCPs that binds to amphiphysin I between amino acids 291 and 375 (11, 14, 16, 20) . Further, both amphiphysin I and II bind directly to clathrin in vitro and in vivo (14, 16, 21) . In fact, clathrin binds to two distinct sites of nine and five amino acids that are conserved between amphiphysin I and II (amino acids 390 -397 and 416 -420 of amphiphysin II) (22) .
Studies aimed at the cloning of amphiphysin II led to the identification of multiple amphiphysin II splice variants (10, 12, 14, (23) (24) (25) (26) (27) ). Interestingly, a major region of splice variability was found within the central domain, which carries the binding sites for clathrin (22) . In fact, the two clathrin-binding sites are carried on separate exons and are restricted to amphiphysin II splice variants expressed in the brain (22, 28) . We also noticed the presence of a 31-amino acid sequence in the N terminus of amphiphysin II (N-terminal insert domain; NTID) that was detected in some, but not all, splice variants (22) . We decided to examine the potential targeting of the amphiphysin II splice variants to CCPs to determine a role for the clathrin-binding domains in this process. Surprisingly, we found that the clathrin-binding domains are not necessary for membrane targeting but that this function appears to be subserved by the N terminus of amphiphysin II.
EXPERIMENTAL PROCEDURES
Antibodies-Affinity purified rabbit polyclonal antibodies against amphiphysin II (1874) (14) and intersectin (29, 30) were prepared as described. A monoclonal antibody against clathrin was produced from the hybridoma X22 (ATCC) and was also kindly supplied by Dr. Mark McNiven (Mayo Clinic). An anti-tetraHis monoclonal antibody was purchased from Qiagen Inc. (Santa Clarita, CA).
Generation of Full-length Amphiphysin II Splice Variants in the Mammalian Expression Vector pcDNA3-Full-length constructs of the amphiphysin II splice variants IIa, IIb, IIc, IIc⌬NTID, and IId were previ-ously generated in pGEX2T (Amersham Pharmacia Biotech) (22) (see Fig.  1 ). The full-length coding sequence for each variant was digested from the plasmid with BamHI and EcoRI and subcloned into the BamHI and EcoRI sites of the mammalian expression vector pcDNA3 (Invitrogen, Carlsbad, CA). Amphiphysin IIa⌬NTID (see Fig. 1 ) was generated by digesting the IMAGE consortium clone described in Ramjaun et al. (14) with SacI and Eco47III and subcloning the 682-base pair fragment into the corresponding region of full-length amphiphysin IIb in pGEX2T described in Ramjaun and McPherson (22) . The full-length amphiphysin IIa⌬NTID construct was subsequently digested with BamHI and EcoRI and subcloned into the corresponding sites of pcDNA3.
Generation of Amphiphysin Splice Variant Deletion Constructs in the Mammalian Expression Vector pcDNA3-Amphiphysin IIa, IIb, IIc, and IId constructs lacking the SH3 domain (see Fig. 1 ) were generated by performing PCR using Vent DNA polymerase (New England Biolabs Ltd., Mississauga, ON, Canada) using a forward primer (5Ј-GCGGGA-TCCATGGCAGAGATGGGCAGTAAAG) corresponding to amino acids 1-7 and a reverse primer (5Ј-ACCTTCCCAGCAACTGTGTGAGAATT-CCGC) corresponding to amino acids 497-502 of amphiphysin IIa (14) . The DNA templates for the reactions were the various amphiphysin II splice variants in pcDNA3 described above. The resulting PCR products were subsequently digested with BamHI and EcoRI and subcloned into pcDNA3. We also generated amphiphysin IIa with 5 and 9 amino acid deletions that remove both clathrin-binding sites (IIa double deletion; see Fig. 1 ). For this construct, the double deletion construct in pGEX2T, described in Ramjaun and McPherson (22) , was completely digested with SmaI and Eco47III to release a 166-base pair fragment containing a region of the insert domain with both deletion sites. This fragment was subcloned into the corresponding region of full-length amphiphysin IIa in pGEX2T after complete Eco47III and partial SmaI digestion. The full coding sequence was then liberated with BamHI and EcoRI and subcloned into the corresponding sites of pcDNA3.
Generation of His 6 -tagged Amphiphysin Deletion Constructs in the Mammalian Expression Vector pcDNA3.1/HisC-An amphiphysin IIa construct missing the first 328 amino acids (amphiphysin IIa⌬NT; see Fig. 7 ) was generated by performing PCR with the forward primer (5Ј-GCGGGATCCCCCAAGTCCCCATCTC) corresponding to amino acids 329 -333 and the reverse primer (5Ј-GCGGAATTCTCATGGGACC-CTCTCAGTG) corresponding to amino acids 589 -593 using full-length amphiphysin IIa as a template. The resulting PCR product was digested with BamHI and EcoRI and then ligated into the corresponding sites of pcDNA3.1/HisC (Invitrogen Co., Carlsbad, CA), which adds a His 6 tag at the N terminus. His 6 -tagged mammalian expression constructs encoding the isolated N termini of amphiphysin II with the NTID (amphiphysin IINT) and without the NTID (amphiphysin IIaNT⌬NTID) were generated by liberating the BamHI/EcoRI fragment from the corresponding construct in pGEX2T, prepared as described below, and subcloning the fragment into pcDNA3.1/HisC.
Generation of Amphiphysin II N-terminal Bacterial Fusion Proteins-GST-and His 6 -tagged bacterial fusion proteins encoding the N termini of amphiphysin II with and without the NTID were generated by performing PCR on full-length amphiphysin IIa and IIa⌬NTID, respectively, using a forward primer corresponding to amino acids 1-7 of amphiphysin II (described above) and the reverse primer (5Ј-GCG-GAATTCTCAGAGGGTGGCCCCGGGC) corresponding to amino acids 324 -328. The resulting PCR products were digested with BamHI and EcoRI and ligated into the corresponding sites of pGEX2T (GST fusion proteins; GST-IINT and GST-IINT⌬NTID) and pTrcHisA (His 6 fusion proteins; His 6 -IINT and His 6 -IINT⌬NTID).
Analysis of Amphiphysin Constructs Expressed in COS-7
Cells-COS-7 cells, transfected with 15-30 g of DNA by calcium phosphate precipitation (31), were processed for analysis 48 h post-transfection. To assess amphiphysin membrane targeting by subcellular fractionation, 10 cm 2 dishes of confluent cells were washed three times with 37°C phosphatebuffered saline (PBS; 50 mM NaH 2 PO 4 , pH 7.4, 150 mM NaCl) and scraped into buffer A (20 mM HEPES-OH, pH 7.4, 0.83 mM benzamidine, 0.23 mM phenylmethylsulfonyl fluoride, 0.5 mg/ml aprotinin, 0.5 mg/ml leupeptin) (1 ml/10 cm 2 dish). The cells were sonicated and passed through a 255 ⁄8 gauge needle, the extracts were centrifuged at 750 ϫ g for 5 min, and the supernatant was subsequently centrifuged at 75,000 rpm for 15 min in a Beckman TL100.2 rotor. To examine membrane targeting by immunofluorescence, COS-7 cells were plated on 22-mm coverslips coated with poly-L-lysine. Cells were then transfected, and plasma membranes were prepared essentially as described (32) . Briefly, cells were maintained for 1 h at 4°C before being washed and sonicated in 12 ml of buffer B (25 mM HEPES, pH 7.0, containing 25 mM KCl, 2.5 mM magnesium acetate, and 0.2 mM dithiothreitol) for 2 s using a 1 ⁄2-inch tapered horn 1 cm above the coverslip at setting 5.0 (Sonics Materials Vibra Cell). In some cases, the cells were washed three times in buffer B and fixed in buffer C (20 mM HEPES, pH 6.8, 100 mM KCl, 5 mM MgCl 2 , 3 mM EGTA, and 3% paraformaldehyde), whereas in other experiments, the cells were washed in different extraction buffers (33), as described in the figure legend, before fixation. Following fixation, coverslips were washed in PBS, incubated for 30 min in PBS containing 5% bovine serum albumin and 5% normal goat serum, washed in PBS, and incubated for 1 h at room temperature with primary antibody in antibody incubation buffer (PBS containing 1% bovine serum albumin). Cells were then washed, incubated for 1 h in fluorescent conjugated secondary antibodies, and mounted on glass slides.
Binding Assays-For binding to GST fusion proteins, adult rat brains were homogenized in 6 volumes of buffer A with a polytron and centrifuged at 750 ϫ g for 5 min, and the supernatant was spun at 45,000 rpm for 1 h in a Beckman Ti50 rotor. The soluble brain extract was diluted to 2 mg/ml in buffer A, and Triton X-100 was added to a final concentration of 1.0%. An aliquot of the extract (0.5 ml) was incubated overnight at 4°C with GST fusion proteins prebound to glutathione-Sepharose. The bead samples were subsequently pelleted by microcentrifugation, washed three times in 1 ml of buffer A with 1% Triton X-100, eluted with SDS gel sample buffer, and prepared for Western blot analysis. Binding to His 6 -tagged fusion proteins was performed essentially as described above for GST fusion proteins except that the buffer A used for incubation and washing contained 20 mM imidazole in addition to 1% Triton X-100. Further, the soluble extract was precleared by a 1-h incubation at 4°C with nickel nitrilotriacetic acid-agarose prior to incubation with His 6 -tagged fusion proteins precoupled to nickel beads.
RESULTS

Amphiphysin II Is Detected at the Plasma Membrane Where
It Partially Co-localizes with Clathrin-Amphiphysin I and II bind to clathrin both in vitro and in vivo (14, 16, 21) . In the case of amphiphysin II, the protein contains two distinct clathrinbinding sites that are differentially incorporated through alternative splicing (22) . To directly assess a potential role for the clathrin-binding domains in amphiphysin subcellular targeting, we transfected COS-7 cells with various amphiphysin II splice variants and then performed immunofluorescence analysis of plasma membranes, prepared with a procedure that leads to membranes rich in CCPs (32) (33) (34) . We first transfected cells with amphiphysin IIa, which contains both clathrin-binding domains (Fig. 1) , and analyzed its targeting to purified plasma membranes by double labeling immunofluorescence with an anti-amphiphysin polyclonal antibody (1874) and a monoclonal antibody against clathrin. We routinely observed numerous, irregularly sized fragments of plasma membrane, which were positive for clathrin (Figs. 2-6 ). In transfected cells, amphiphysin IIa was detected on the plasma membrane where it displayed a bright, highly punctate distribution ( Fig.  2A ; note the amphiphysin II staining on the plasma membrane from a transfected cell in example 2 relative to the plasma membrane for the two nontransfected cells in the same field). Clathrin also displayed a punctate distribution, but the pattern was more discrete (Fig. 2A) . When images were superimposed, amphiphysin IIa was found to be partially, but not completely, co-localized with clathrin ( Fig. 2A) . Quantitation of five separate cells revealed that 62% of all CCPs contained amphiphysin II, whereas 45% of the total amphiphysin II was found at CCPs (Fig. 2C) . To better understand the degree of colocalization of amphiphysin II with CCPs, we compared its colocalization to that of intersectin, a protein containing two N-terminal Eps15 homology (EH) domains and five C-terminal SH3 domains (29, 30, 35, 36) . Through its EH domains, intersectin binds to Ibp2/ epsin, proteins that also interact with clathrin and AP2 and appear to localize intersectin (and its isolated EH domains) to CCPs (30, 37) (Fig. 2B) . Quantitation of the colocalization of the EH domains of intersectin with CCPs revealed that 82% of all CCPs contain intersectin EH domains and that 81% of the intersectin EH domain protein is at CCPs (Fig. 2C) . Thus, a significant percentage of amphiphysin II is directed to CCPs, although the percentage is not as high as that for intersectin, and amphiphysin II is also found at areas of the plasma membrane that do not contain CCPs.
Amphiphysin II Clathrin-binding Domains Do Not Mediate Membrane Targeting-To determine whether the clathrinbinding domains of amphiphysin II mediate membrane targeting, we transfected cells with amphiphysin IIa and IId, both of which contain the clathrin-binding domains, and amphiphysin IIb and IIc, which do not contain clathrin-binding domains (Fig. 1) . Amphiphysin IIa and IId were localized to the plasma membrane, whereas amphiphysin IIb was not detected on membranes (Fig. 3A) . Surprisingly, amphiphysin IIc was found at the membrane. All of the constructs were expressed at approximately equal levels as determined by Western blots of extracts prepared from transfected cells (Fig. 3B) . These data suggest that clathrin binding may not be necessary for amphiphysin II membrane localization.
To further explore this issue, we treated the isolated plasma membrane preparations with 0.5 M Tris-HCl, pH 7.0, or 1 M NaCl, which was sufficient to extract clathrin but did not appear to affect the distribution of amphiphysin IIa (Fig. 4) . These results are in agreement with previous studies on dynamin (32) in which the protein resisted extraction under similar conditions and further demonstrate that interactions of amphiphysin II with clathrin are not necessary for the stable association of amphiphysin II with the plasma membrane.
SH3 domains can direct subcellular targeting of soluble proteins (38) . To determine whether the SH3 domain of amphiphysin II targets the protein to the membrane, we deleted this module from amphiphysin IIa, IIb, IIc, and IId. As for the full-length proteins, amphiphysin IIa⌬SH3, IIc⌬SH3, and IId⌬SH3 were targeted to the plasma membrane, whereas IIb⌬SH3 was not detected at the membrane (Fig. 5) , demonstrating that the amphiphysin II SH3 domain is not responsible for membrane targeting. The results obtained with the various constructs are summarized in Fig. 1 .
The N-terminal Insert Domain of Amphiphysin II Plays a Role in Plasma Membrane Targeting-Examination of the various amphiphysin II constructs revealed that all proteins that targeted to the plasma membrane (IIa, IIc, IId, IIa⌬SH3, IIc⌬SH3, and IIdSH3) contained the 31 amino acid NTID (Fig.  1) , whereas proteins that did not target (IIb and IIb⌬SH3) were lacking this domain. To examine a role for the NTID in membrane targeting, we compared the localization of the amphiphysin II splice variants IIc and IIc⌬NTID, which are identical except for the presence or absence, respectively, of the NTID (Fig. 1 ). In addition, we compared the targeting of amphiphysin IIa to that of a construct (amphiphysin IIa⌬NTID) that is identical to amphiphysin IIa but lacks the NTID. Interestingly, both amphiphysin IIa and IIc were found at the membrane, whereas amphiphysin IIa⌬NTID and IIc⌬NTID were never detected at the membrane (Fig. 6) , suggesting a role for the 31-amino acid NTID in membrane localization.
To further examine a role for the NTID in membrane targeting, we transfected COS-7 cells with amphiphysin IIa and IIa⌬NTID and then fractionated cell extracts by centrifugation to yield soluble and particulate compartments. Western blot analysis revealed that amphiphysin IIa was enriched in the particulate fraction relative to the homogenate, whereas amphiphysin IIa⌬NTID was present at much lower levels in the particulate fraction relative to the homogenate or to the levels of amphiphysin IIa in the particulate fraction (Fig. 7B) . To further explore this issue, we generated constructs in which we deleted the entire N terminus from amphiphysin IIa (amphiphysin IIa⌬NT) or in which we expressed the isolated N terminus of amphiphysin II with (amphiphysin IINT) or without (amphiphysin IINT⌬NTID) the NTID (Fig. 7A) . All three constructs contained a six-histidine tag at the N terminus. The plasmids were transfected in COS-7 cells, and extracts were separated into soluble and particulate fractions that were blotted with an anti-tetraHis monoclonal antibody. Amphiphysin IIa⌬NT was found entirely in the soluble fraction (Fig. 7C) . In contrast, amphiphysin IINT was found entirely in the membrane fraction, and amphiphysin IINT⌬NTID was evenly distributed between the soluble and membrane fraction (Fig. 7C) . These data confirm an important role for the N terminus of amphiphysin II in membrane interactions and further support a role for the NTID in this process.
The N Terminus of Amphiphysin II Mediates Amphiphysin Dimerization-To better understand the mechanisms involved in targeting amphiphysin II to the membrane, we generated GST fusion proteins encoding the N terminus of amphiphysin II with (GST-IINT) or without (GST-IINT⌬NTID) the NTID, which we then used for affinity purification of detergent solubilized COS-7 cell and rat brain extracts in an attempt to identify an amphiphysin II membrane receptor. Coomassie Blue-stained gels of the affinity purified samples failed to identify a candidate receptor protein. However, Western blot analysis of the samples with an antibody against amphiphysin I and II revealed that both proteins bound to the N-terminal fusion proteins (Fig. 8A) , consistent with the observation that the amphiphysins dimerize through the N terminus (10, 16) . Interestingly, both amphiphysin I and II appeared to bind more strongly to GST-IINT than to GST-IINT⌬NTID, despite the fact that the former fusion protein, as detected by an antibody against GST, was present at much lower levels on the glutathione-Sepharose beads (because of lower levels of bacterial expression) (Fig. 8A) . Similar results were obtained when the N-terminal constructs were expressed as His 6 -tagged fusion proteins and coupled to nickel-agarose for the affinity selection experiments (Fig. 8B) . These results suggest that the NTID of amphiphysin II may play a role in amphiphysin dimerization.
DISCUSSION
Amphiphysin I and II are nerve terminal-enriched proteins that interact through their SH3 domains with proline-rich sequences in synaptojanin and dynamin and display SH3 domain-independent interactions with AP2 and clathrin (38) . Thus, it has been suggested that the amphiphysins function as adaptor proteins in synaptic vesicle endocytosis by recruiting synaptojanin and dynamin to emerging endocytic sites in the nerve terminal. However, a direct role for AP2-and clathrinbinding in amphiphysin membrane targeting has not been demonstrated.
Recently, several groups have reported the sequence of a large number of alternatively spliced variants of amphiphysin II (10, 12, 14, 23-27 ). Interestingly, amphiphysin II splice variants isolated from human brain cDNA demonstrate alternative exon usage within the central region including the two exons that encode the two distinct clathrin-binding domains (22, 28) . We therefore decided to examine the potential role of the clathrin-binding domains in targeting amphiphysin II to endocytic sites on the plasma membrane using a procedure that generates highly purified preparations of plasma mem- branes, rich in CCPs, from cultured cells. This technique has been used effectively to study the assembly of CCPs (39) as well as to dissect the mechanisms of CCP targeting in proteins such as dynamin (32) , Eps15 (33) , and intersectin (30) . Thus, we generated plasma membranes from COS-7 cells following transfection with full-length amphiphysin IIa. Immunofluorescence analysis revealed that the protein was targeted to the plasma membrane where it was co-localized, in part, with clathrin. Quantitation of these data revealed that 62% of all CCPs contained amphiphysin II, whereas only 45% of the total amphiphysin II was found at CCPs. These results are reminiscent of those seen with dynamin, using an identical assay in which the protein was found to be predominantly co-localized with clathrin but was also found on the membrane at sites that were devoid of CCPs (32) . These findings are also consistent with those of Bauerfeind et al. (40) in which immunogold labeling for amphiphysin I in nerve terminals treated with GTP␥S revealed that the protein was associated with clathrincoated endocytic intermediates but that clathrin-coated structures devoid of amphiphysin I labeling were observed.
We next examined the membrane targeting of amphiphysin II splice variants lacking the clathrin-binding domains. Interestingly, several splice variants and deletion constructs that do not bind clathrin are still targeted to the plasma membrane, strongly suggesting that the clathrin-binding domains are not necessary for membrane targeting. Amphiphysin I is well established to interact with AP2 (11, 20) , and it has been reported that amphiphysin II also binds to AP2 (12). Thus, it is possible that interactions with AP2 may target amphiphysin II to the plasma membrane. However, this appears unlikely because extraction of membranes with 0.5 M Tris, pH 7.0, which is sufficient to remove clathrin and significantly reduce AP2 (33), does not appear to affect amphiphysin II membrane targeting. Further, the AP2-binding site on amphiphysin I has been localized to a region between amino acids 322 and 375 (16, 41) , and the corresponding region of amphiphysin II is lacking in amphiphysin IIc, which targets to the plasma membrane.
Examination of the plasma membrane targeting of multiple amphiphysin II constructs using immunofluorescence analysis revealed that targeting was dependent on the presence of the NTID (Fig. 1) . For example, amphiphysin IIa and IIc (both containing the NTID) were found at the membrane, whereas amphiphysin IIa⌬NTID and IIc⌬NTID (which are identical to IIa and IIc, respectively, except that they lack the NTID), were not detected at the membrane. The 31-amino acid NTID is found in most of the amphiphysin II splice variants that have been identified, including amphiphysin IIa, the variant that appears to be the predominant form expressed in brain (10, 12,
FIG. 7. Subcellular fractionation of amphiphysin II constructs.
A, domain models of the various amphiphysin II constructs examined by subcellular fractionation. The N-terminal domain, NTID, SH3 domain, and binding sites for clathrin and endophilin (22, 43) are indicated. 9 and 5 represent the two clathrin-binding sites identified in amphiphysin II (22) . The His 6 represents a six-histidine tag added to some of the constructs. The figure was adapted from Ref. 22 . B, confluent COS-7 cells transfected with amphiphysin IIa (amphi. IIa) or IIa⌬NTID (amphi. IIa⌬NTID) were disrupted and separated into soluble (sup.) and particulate (pellet) fractions by ultracentrifugation. Equal aliquots of the fractions were separated on SDS-polyacrylamide gel electrophoresis along with an equivalent aliquot of the crude lysate (homog.). The two blots were processed by Western blot with an antibody against amphiphysin II under identical conditions. C, COS-7 cells were transfected with amphiphysin IIa⌬NT, amphiphysin IINT, or amphiphysin IINT⌬NTID as described for A. Confluent cells were disrupted and separated into soluble (sup.) and particulate (pellet) fractions by ultracentrifugation. Equal aliquots of the fractions were separated on SDS-polyacrylamide gel electrophoresis along with an equivalent aliquot of the crude lysate (homog.) and were processed for Western blot with an anti-tetraHis monoclonal antibody.
FIG. 8. The N terminus of amphiphysin II mediates amphiphysin dimerization.
A, GST fusion proteins encoding the N terminus of amphiphysin II (amino acids 1-328) with (GST-IINT) or without (GST-IINT⌬NTID) the NTID, as well as GST alone, were incubated with glutathione-Sepharose. The washed beads were then incubated with soluble extracts from rat brain, and proteins specifically bound to the beads were resolved by SDS-polyacrylamide gel electrophoresis and processed for Western blots along with an aliquot of the soluble brain extract. SM, starting material. The top half of the blot (top panel) was reacted with an antibody raised against amphiphysin II, which recognizes both amphiphysin I (amphi. I) and II (amphi. II). The bottom half of the blot (bottom panel) was reacted with an antibody against GST. The migratory positions of the various fusion proteins are indicated by arrows. B, His 6 -tagged proteins encoding the N terminus of amphiphysin II (amino acids 1-328) with (His 6 -IINT) or without (His 6 -IINT⌬NTID) the NTID were incubated with nickel nitrilotriacetic acidagarose. The washed beads were then incubated with soluble extracts from rat brain, and proteins specifically bound to the beads were processed for Western blots as described in A. The top half of the blot (top panel) was reacted with an antibody raised against amphiphysin II, which recognizes both amphiphysin I (amphi. I) and II (amphi. II). The bottom half of the blot (bottom panel) was reacted with an anti-tetraHis monoclonal antibody. The migratory positions of the His 6 fusion proteins are indicated by arrows. 14, 22, 25, 26) . To further explore a role for the NTID in membrane targeting, we fractionated cells, transfected with amphiphysin IIa or IIa⌬NTID, into soluble and particulate compartments by high speed centrifugation. Whereas amphiphysin IIa was found predominantly in the particulate fraction, IIa⌬NTID was present at much lower levels in the particulate fraction. Similar results were seen from cells transfected with constructs encoding the isolated N terminus of amphiphysin II (amino acids 1-328) with (amphiphysin IINT), or without (amphiphysin IINT⌬NTID), the NTID. Specifically, amphiphysin IINT was enriched in the membrane fraction relative to the homogenate, whereas amphiphysin IINT⌬NTID was present at lower levels in the membrane fraction relative to the homogenate. However, for both amphiphysin IIa⌬NTID and amphiphysin IINT⌬NTID, a pool of the protein was detected on the membrane. This suggests that N-terminal sequences outside of the NTID can also function in membrane interactions. Thus, the lack of membrane targeting in the immunofluorescence assay of constructs that contain the N terminus but lack the NTID may reflect the more stringent wash conditions used in this assay. Taken together, these data suggest that the N terminus of amphiphysin II mediates the proteins targeting to the membrane and that the NTID plays a significant role in this phenomenon.
Previously, it was demonstrated that dynamin can tubulate protein-free liposomes (3, 4) . Intriguingly, Takei et al. (42) have recently demonstrated that purified amphiphysin I can also tubulate protein-free liposomes, suggesting that amphiphysin I can interact directly with lipids. Of interest, analysis of protein fragments revealed that the N terminus of amphiphysin I was responsible for the tubulation activity (42) . Full-length amphiphysin I demonstrates similar membrane targeting as fulllength amphiphysin II in our assay (data not shown). Thus, the N terminus of the amphiphysins appear to contain sequences that allow for interactions with the plasma membrane, possibly through direct protein-lipid interactions (42) .
How then, may the NTID be involved in this phenomenon? A clue to this question may come from the observation that the NTID appears to function in amphiphysin dimerization. Previously, McMahon and colleagues (10) determined that the amphiphysins form heterodimers. More recently, De Camilli and colleagues (16) demonstrated that the N terminus of amphiphysin I could bind directly to both amphiphysin I and II, suggesting that the amphiphysins can form hetero-and homodimers and that dimerization is mediated through the N terminus. Consistent with this result, we have found that fusion proteins encoding the N terminus of amphiphysin II can bind to both amphiphysin I and II from brain extracts. The N termini of amphiphysin I and II are rich in charged amino acids and contain long stretches of high ␣-helical potential with high probabilities of participating in coiled-coil interactions. Thus, it is perhaps not surprising that the NTID is not necessary for dimerization (for example, amphiphysin IIa⌬NTID, expressed in COS-7 cells, binds to GST-IINT⌬NTID, data not shown). However, the presence of the NTID in the N-terminal domain fusion proteins leads to greater amphiphysin binding. Thus, the NTID appears to facilitate amphiphysin dimerization mediated by helical sequences in the N terminus. This property of the NTID may be related to its role in amphiphysin targeting to the plasma membrane.
Thus, it appears that the N terminus of the amphiphysins mediate the targeting of these proteins to the plasma membrane. Future avenues of research should include establishing the precise mechanism by which the N terminus of amphiphysin mediates membrane binding, the mechanism by which the NTID functions in this process, and determining the role for clathrin binding in amphiphysin function.
